These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Effect of miscleron on various indicators of blood coagulation in ischemic heart disease]. Deriagina GP Kardiologiia; 1977 Mar; 17(3):141-2. PubMed ID: 886690 [No Abstract] [Full Text] [Related]
4. Clofibrate and the prevention of ischaemic heart disease. N Z Med J; 1979 Jun; 89(637):435-6. PubMed ID: 289017 [No Abstract] [Full Text] [Related]
5. Clofibrate and the primary prevention of ischaemic heart disease. Br Med J; 1978 Dec; 2(6152):1585-6. PubMed ID: 728731 [No Abstract] [Full Text] [Related]
6. Cholesterol, clofibrate and ischaemic heart disease. Facts and emotions around. Fejfar Z Cor Vasa; 1979; 21(6):377-9. PubMed ID: 397875 [No Abstract] [Full Text] [Related]
7. [Clofibrate--facts and controversies]. Sznajderman M Pol Arch Med Wewn; 1980 Feb; 63(2):101-6. PubMed ID: 7360682 [No Abstract] [Full Text] [Related]
8. Mechanism of action of clofibrate. Sirtori CR Lancet; 1981 Jun; 1(8234):1362. PubMed ID: 6113326 [No Abstract] [Full Text] [Related]
9. A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Report from the Committee of Principal Investigators. Br Heart J; 1978 Oct; 40(10):1069-118. PubMed ID: 361054 [No Abstract] [Full Text] [Related]
11. A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Miettinen M; Turpeinen O; Karvonen MJ Br Heart J; 1979 Sep; 42(3):370-1. PubMed ID: 508466 [No Abstract] [Full Text] [Related]
12. WHO cooperative trial on primary prevention of ischaemic heart disease with clofibrate to lower serum cholesterol: final mortality follow-up. Report of the Committee of Principal Investigators. Lancet; 1984 Sep; 2(8403):600-4. PubMed ID: 6147641 [TBL] [Abstract][Full Text] [Related]
13. Clofibrate and niacin in coronary heart disease. JAMA; 1975 Jan; 231(4):360-81. PubMed ID: 1088963 [No Abstract] [Full Text] [Related]
14. [Use of Clofibrate Spofa in the prevention of ischemic heart disease]. Geizerová H; Grafnetter D; Hejl Z Cas Lek Cesk; 1972 Jun; 111(20):466-9. PubMed ID: 5046003 [No Abstract] [Full Text] [Related]
15. A cooperative trial in the primary prevention of ischaemic heart disease using clofibrate: some statistical aspects. Heady JA Control Clin Trials; 1981 May; 1(4):383-92. PubMed ID: 7261629 [TBL] [Abstract][Full Text] [Related]
16. [Clofibrate in the primary prevention of coronary disease]. Bjerkelund C Tidsskr Nor Laegeforen; 1979 Sep; 99(25):1199-1201. PubMed ID: 505440 [No Abstract] [Full Text] [Related]
17. [Miscleron in the treatment of patients with atherosclerosis of the coronary and cerebal vessels]. Sivkov II; Kukes VG; Kirichenko LL; Fedosova NS; Ishmaeva KA Sov Med; 1971 Sep; 34(9):54-7. PubMed ID: 5121295 [No Abstract] [Full Text] [Related]
18. Study of serum lipid fractions as related to blood coagulation, fibrinolysis and platelet aggregation in cholesterol fed rabbits and in arteriosclerotic patients given clofibrate. Baldoni E; Egge H; Cuttin S; Murawski U; Gibelli A; Giarola P Farmaco Sci; 1973 Sep; 28(9):713-21. PubMed ID: 4749857 [No Abstract] [Full Text] [Related]
19. Status of antiplatelet drugs in coronary heart disease. Mehta J; Mehta P JAMA; 1979 Jun; 241(24):2649-51. PubMed ID: 439365 [No Abstract] [Full Text] [Related]
20. W.H.O. cooperative trial on primary prevention of ischaemic heart disease using clofibrate to lower serum cholesterol: mortality follow-up. Report of the Committee of Principal Investigators. Lancet; 1980 Aug; 2(8191):379-85. PubMed ID: 6105515 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]